Why is Valiant Laborato falling/rising?

As of 03-Jul, Valiant Laboratories Ltd is experiencing a price increase, currently at 115.75, which reflects a rise of 1.95 or 1.71%. The stock has shown positive momentum, gaining 3.67% over the last two days and outperforming its sector by 1.23% today. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Additionally, the company reported positive results for the last six months, with a higher profit after tax of Rs 3.05 crore and record net sales of Rs 57.79 crore. However, despite these positive indicators, the company faces challenges such as weak long-term fundamental strength, with an average return on equity of 0% and negative EBITDA, which may impact investor sentiment.
In the broader market context, Valiant Laboratories has outperformed the Sensex in the short term, with a 1-week return of +2.34% compared to the benchmark's -0.62%. While the stock has shown some recovery in the short term, it has underperformed against the benchmark over the longer term, with a 1-year return of -17.00% versus the Sensex's +4.07%. The increasing participation of institutional investors, who have raised their stake by 0.64%, may provide some support for the stock, but the overall weak long-term growth and consistent underperformance against broader indices remain significant concerns for potential investors.